Načítá se...
Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy
The present study describes the development of a good manufacturing practice (GMP)-grade liposomal nanotherapy containing prednisolone phosphate for the treatment of inflammatory diseases. After formulation design, GMP production was commenced which yielded consistent, stable liposomes sized 100 nm...
Uloženo v:
| Vydáno v: | Nanomedicine |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4495976/ https://ncbi.nlm.nih.gov/pubmed/25791805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2015.02.020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|